You are here: Industry Insights > SARS-CoV-2

News List

ImmunityBio COVID-19 vaccine candidate shows protection of airways in non-human primates expresspharma
December 14, 2020
The hAd5-COVID-19 candidate is designed to address a potential problem that may emerge when first-generation adenoviral platforms are used as vaccine vectors: vaccine inactivation due to pre-existing immunity to the vector itself.
Oral drug blocks SARS-CoV-2 transmission worldpharmanews
December 11, 2020
Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University have discovered.
Studies Reveal Potential Weaknesses in SARS-CoV-2 Infection prnewswire
December 11, 2020
A single protein that appears necessary for the COVID-19 virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies.
Avacta Announces SARS-CoV-2 Rapid Antigen Test Update americanpharmaceuticalreview
December 08, 2020
Avacta Group has announced progress in the development of a highly scalable manufacturing process for a lateral flow SARS-CoV-2 antigen test being carried out with BBI Solutions, and that the lateral flow test has very good analytical sensitivity with ...
Sosei Heptares' COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules americanpharmaceuticalreview
December 07, 2020
Sosei announces a progress update for its R&D program focused on the design and development of novel drugs targeting the SARS-CoV-2 coronavirus and to treat COVID-19.
IPC Statement On SARS-CoV-2 Vaccines And Psoriasis prnasia
December 03, 2020
The SARS-CoV-2 pandemic continues to have a considerable impact on the provision of appropriate care to people with psoriasis.
EMA initiates rolling review of Janssen’s Covid-19 vaccine candidate pharmaceutical-technology
December 03, 2020
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has initiated a rolling review of Janssen and Cilag International’s Covid-19 vaccine candidate, Ad26.COV2.S.
ELITechGroup MDx Announces EUA Submission for SARS-CoV-2 Plus ELITe MGB Assay americanpharmaceuticalreview
December 02, 2020
ELITechGroup MDx has submitted the SARS-CoV-2 Plus ELITe MGB® Assay to the U.S. Food & Drug Association's (FDA's) for Emergency Use Authorization (EUA), following the Molecular Diagnostic Template for Commercial Manufacturers.
Predict cellular drug targets against COVID-19 worldpharmanews
November 30, 2020
A computational model of a human lung cell has been used to understand how SARS-CoV-2 draws on human host cell metabolism to reproduce by researchers at the University of Warwick.
Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies prnewswire
November 26, 2020
Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for COVID-SeroKlir, its semi-quantitative SARS-CoV-2 IgG ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page